Scientific Evaluation of Modified Risk Tobacco Product Applications; Public Workshop
Document ID: FDA-2011-N-0443-0001
Comments
Total: 56
-
Miya - Comment
Posted : 07/15/2011 ID ：FDA-2011-N-0443-0002 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
American Cancer Society (ACS), Cancer Action Network (CAN), American Heart Association (AHA), American Lung Association (ALA), Campaign for Tobacco-Free Kids (TFK), American Public Health Association (APHA) - Comment
Posted : 09/23/2011 ID ：FDA-2011-N-0443-0003 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Gilbert L. Ross - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0004 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Peter Shields - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0005 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Jim Tozzi (Center for Regulatory Effectiveness) - Testimony
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0006 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Gilbert Ross M.D. - Testimony
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0007 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Patrick Johnson - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0008 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Leena Bhola - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0009 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Matthew Carpenter - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0010 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Scott Douglas Ballin - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0011 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Kerry Scott Lane MD - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0012 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
British American Tobacco (Investments) Ltd - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0013 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
IMPERIAL TOBACCO LIMITED - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0014 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
UNC Tobacco Research Program - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0015 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
James Dixon Gardner - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0016 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
David Pearl - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0017 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Robert W Hubbard - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0018 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Laura M Romito - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0019 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Alan - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0020 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
American Congress of Obstetricians and Gynecologists (ACOG) - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0021 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Jason William Healy - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0022 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Travis Humphrey - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0023 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Lisa E. Bell - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0024 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
James Patrick McCord - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0025 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Donna Fleming - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0026 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Legacy - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0027 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Kevin Scott Brown - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0028 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Sheri A Bowman - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0029 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Mark Strazzer - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0030 Agency : FDA -
Sep 23,2011 11:59 PM ET
-
Lorillard Tobacco Company Inc. - Comment
Posted : 09/28/2011 ID ：FDA-2011-N-0443-0031 Agency : FDA -
Sep 23,2011 11:59 PM ET